宫颈管细胞学检查在诊断子宫内膜癌中的价值

首都医科大学学报 ›› 2004, Vol. 25 ›› Issue (3): 394-396.

宫颈管细胞学检查在诊断子宫内膜癌中的价值

徐小红, 刘悦, 潘静, 邓小虹

首都医科大学附属北京妇产医院肿瘤科

收稿日期:2003-07-29 修回日期:1900-01-01 出版日期:2004-07-15 发布日期:2004-07-15

Endocervical Cytology in Diagnosis of Endometrial Carcinoma

Xu Xiaohong, Liu Yue, Pan Jing, Deng Xiaohong

Department of Gynecological Oncology, Beijing Obstetric and Genecology Hospital, Affiliate of Capital University of Medical Sciences

Received:2003-07-29 Revised:1900-01-01 Online:2004-07-15 Published:2004-07-15

摘要/Abstract

摘要： 应用瑞典欧立宫颈管毛刷获取宫颈管细胞,对1093例需进行分段诊刮术的病人进行细胞学检查,并与以分段诊刮术或子宫全切术获得的子宫内膜组织的病理结果进行比较.结果:宫颈管毛刷和宫颈管搔刮术取材满意率分别为82.5%和17.0%.60例子宫内膜癌病人中48例接受了分期手术,其中14例宫颈受累.在判断宫颈是否受累方面,宫颈管细胞学的敏感性为71.4%,特异性为82.4%;宫颈管搔刮术的敏感性为50.0%,特异性为79.4%.提示:宫颈管细胞学检查阳性不一定代表宫颈管受累,但对术前决定分期、术式和判断预后有一定的参考价值.

关键词: 子宫内膜癌, 宫颈管细胞学, 细胞学诊断

Abstract: To determine the value of endocervical cytology in detecting endometrial carcinoma, endocervical cells were assessed by Ori Endocervical Brush TM for 1 093 patients who accepted fractioned curettage.Cytodiagnostic results were compared with the histodiagnostic results, which were regarded as the golden standard.The achieving efficiency of endocervical brush smears and endocervical curettage's (ECCs) were 82.5% and 17.0% respectively.Of the 60 cases with endometrial carcinoma, 48 cases accepted staging operation, and 14 cases had cervical involvement.In judging the cervical involvement, the sensitivity and specificity of endocervical smears were 71.4% and 82.4%, respectively.While in ECCs, there were 50.0% and 79.4%, respectively.The cases reported as positive by endocervical cytology mostly have higher stage, higher grade and special histological type, which is useful in preoperative staging and deciding the type of operation.

Key words: endometrial carcinoma, endocervical cytology, cytodiagnosis

中图分类号:

R737.33

徐小红;刘悦;潘静;邓小虹. 宫颈管细胞学检查在诊断子宫内膜癌中的价值[J]. 首都医科大学学报, 2004, 25(3): 394-396.

Xu Xiaohong;Liu Yue;Pan Jing;Deng Xiaohong. Endocervical Cytology in Diagnosis of Endometrial Carcinoma[J]. Journal of Capital Medical University, 2004, 25(3): 394-396.

[1]	张颖, 段华. 宫腔镜在子宫内膜癌高危因素评估中的应用进展[J]. 首都医科大学学报, 2021, 42(2): 214-218.
[2]	黄文阳, 郑晓娟, 蒋英, 王淑珍. 子宫内膜不典型增生患者术后病理升级的特征分析[J]. 首都医科大学学报, 2019, 40(6): 846-850.
[3]	马旭兰, 夏迪, 王慧霄, 蒋子雯, 代荫梅. 雌激素通过介导HOTAIR表达对子宫内膜癌细胞增生及裸鼠致瘤能力的影响[J]. 首都医科大学学报, 2019, 40(6): 894-900.
[4]	刘晨, 吴龙, 蒋宏传, 李杰, 刘军, 王淑珍. 乳腺癌术后并发妇科生殖道恶性肿瘤的高危因素分析[J]. 首都医科大学学报, 2017, 38(1): 92-96.
[5]	崔开宇;孔宪超. 肿瘤干细胞在子宫内膜癌的诊断与治疗中的研究进展[J]. 首都医科大学学报, 2012, 33(2): 280-283.
[6]	邢风玲;陈雪芹;冯力民;张华. 绝经后服用他莫西芬的乳腺癌患者子宫内膜中PTEN的表达[J]. 首都医科大学学报, 2010, 31(3): 405-408.
[7]	杨保军;邢凤玲;冯力民;张华;孙海梅. 它莫西芬对子宫内膜血管内皮生长因子表达的影响[J]. 首都医科大学学报, 2007, 28(3): 412-414.
[8]	杨淑丽;吴玉梅;孔为民;邓小虹. 子宫内膜癌治疗方法的评价[J]. 首都医科大学学报, 2005, 26(5): 584-587.
[9]	周莲娥. 术前血清CA₁₂₅在子宫内膜癌评估中的意义[J]. 首都医科大学学报, 2003, 24(2): 199-200.